NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589–604. doi:10.1038/s41575-019-0186-y31439937
   PubMed Web of Science ®Google Scholar
• Choi SH, Park JY. Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference. Cancer Cell Int. 2017;17:3. doi:10.1186/s12935-016-0374-628053598
   PubMed Web of Science ®Google Scholar
• Xiong XX, Qiu XY, Hu DX, Chen XQ. Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma. Mol Pharmacol. 2017;92:246–255. doi:10.1124/mol.116.10770628242743
   PubMed Web of Science ®Google Scholar
• Lim LJ, Wong SYS, Huang F, et al. Roles and regulation of long noncoding RNAs in hepatocellular carcinoma. Cancer Res. 2019;79:5131–5139. doi:10.1158/0008-5472.CAN-19-025531337653
   PubMed Web of Science ®Google Scholar
• Huo X, Han S, Wu G, et al. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16:165. doi:10.1186/s12943-017-0734-429061150
   PubMed Web of Science ®Google Scholar
• Dong J, Xu J, Wang X, Jin B. Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis. Tumour Biol. 2016;37:1379–1385. doi:10.1007/s13277-015-4457-026608368
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao S, Mingxin YU. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4. Pharmazie. 2019;74:295–300.31109400
   PubMed Web of Science ®Google Scholar
• Guo F, Fu Q, Wang Y, Sui G. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. J Cell Mol Med. 2019;23:5907–5919. doi:10.1111/jcmm.1438631304680
   PubMed Web of Science ®Google Scholar
• Li S, Zheng K, Pei Y, Wang W, Zhang X. Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p. Aging (Albany NY). 2019;11:11609–11623. doi:10.18632/aging.10256331801112
   PubMedGoogle Scholar
• Huang H, Chen J, Ding CM, Jin X, Jia ZM, Peng J. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363. J Cell Mol Med. 2018;22:3238–3245. doi:10.1111/jcmm.1360529602203
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, Deng Z, Jiang R, Wang X. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70:1298–1316. doi:10.1002/hep.3067131004447
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang F, Deng L, et al. HIF-1-miR-219-SMC4 regulatory pathway promoting proliferation and migration of HCC under hypoxic condition. Biomed Res Int. 2019;2019:8983704. doi:10.1155/2019/898370431828143
   PubMedGoogle Scholar
• Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev. 2015;81:62–74. doi:10.1016/j.addr.2014.10.02925450260
   PubMed Web of Science ®Google Scholar
• Truettner JS, Katyshev V, Esen-Bilgin N, Dietrich WD, Dore-Duffy P. Hypoxia alters MicroRNA expression in rat cortical pericytes. Microrna. 2013;2:32–44.24883265
   PubMedGoogle Scholar
• Li Y, Liu G, Li X, Dong H, Xiao W, Lu S. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochem Biophys Res Commun. 2018;503:2826–2832. doi:10.1016/j.bbrc.2018.08.04730115383
   PubMed Web of Science ®Google Scholar
• Hou ZH, Xu XW, Fu XY, Zhou LD, Liu SP, Tan DM. Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140. Am J Physiol Cell Physiol. 2020;318:649–663. doi:10.1152/ajpcell.00510.2018
   Web of Science ®Google Scholar
• DeWaal D, Nogueira V, Terry AR, et al. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018;9:446. doi:10.1038/s41467-017-02733-429386513
   PubMed Web of Science ®Google Scholar
• Chai F, Li Y, Liu K, Li Q, Sun H. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism. J Cell Physiol. 2019;234:1937–1946. doi:10.1002/jcp.2707430144070
   PubMed Web of Science ®Google Scholar
• Zhang CY, Jiang ZM, Ma XF, et al. Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia. Front Pharmacol. 2019;10:1039. doi:10.3389/fphar.2019.0103931616295
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Villanueva A, Longo DL. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–1462. doi:10.1056/NEJMra171326330970190
   PubMed Web of Science ®Google Scholar
• Nath B, Szabo G. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology. 2012;55:622–633. doi:10.1002/hep.2549722120903
   PubMed Web of Science ®Google Scholar
• Abbastabar M, Sarfi M, Golestani A, Khalili E. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 2018;17:900–913.30564069
   PubMed Web of Science ®Google Scholar
• Shih JW, Kung HJ. Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena. J Biomed Sci. 2017;24:53. doi:10.1186/s12929-017-0358-428789687
   PubMed Web of Science ®Google Scholar
• Chang YN, Zhang K, Hu ZM, et al. Hypoxia-regulated lncRNAs in cancer. Gene. 2016;575:1–8. doi:10.1016/j.gene.2015.08.04926341058
   PubMed Web of Science ®Google Scholar
• Shang RZ, Qu SB, Wang DS. Reprogramming of glucose metabolism in hepatocellular carcinoma: progress and prospects. World J Gastroenterol. 2016;22:9933–9943. doi:10.3748/wjg.v22.i45.993328018100
   PubMed Web of Science ®Google Scholar
• Jin F, Wang Y, Zhu Y, et al. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma. Sci Rep. 2017;7:3089. doi:10.1038/s41598-017-03407-328596599
   PubMed Web of Science ®Google Scholar
• Ren L, Yao Y, Wang Y, Wang S. MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R. Biosci Rep. 2019;39:BSR20182442. doi:10.1042/BSR2018244231160483
   PubMed Web of Science ®Google Scholar
• Wong CC, Kai AK, Ng IO. The impact of hypoxia in hepatocellular carcinoma metastasis. Front Med. 2014;8:33–41. doi:10.1007/s11684-013-0301-324234682
   PubMed Web of Science ®Google Scholar
• Yang C, Liu Z, Chang X, et al. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. J Cell Biochem. 2020;121:2009–2018. doi:10.1002/jcb.2943531692033
   PubMed Web of Science ®Google Scholar
• Wang ZY, Zhu Z, Wang HF, et al. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p. J Cell Physiol. 2019;234:17775–17785. doi:10.1002/jcp.2840330864145
   PubMed Web of Science ®Google Scholar
• Yan X, Zhu Z, Xu S, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915. doi:10.1038/srep4591528383568
   PubMed Web of Science ®Google Scholar
• Liu L, Li TM, Liu XR, et al. MicroRNA-140 inhibits skeletal muscle glycolysis and atrophy in endotoxin-induced sepsis in mice via the WNT signaling pathway. Am J Physiol Cell Physiol. 2019;317:189–199. doi:10.1152/ajpcell.00419.2018
   Web of Science ®Google Scholar
• He Y, Deng F, Zhao S, et al. Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1. Epigenomics. 2019;11:1021–1036. doi:10.2217/epi-2019-007231184216
   PubMed Web of Science ®Google Scholar
• Feng J, Li J, Wu L, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:126.32631382
   PubMed Web of Science ®Google Scholar
• Huang M, Xiong H, Luo D, Xu B, Liu H. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Exp Cell Res. 2020;388:111876. doi:10.1016/j.yexcr.2020.11187631991125
   PubMed Web of Science ®Google Scholar
• Ding Z, Guo L, Deng Z, Li P. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Ann Hepatol. 2020;19:269–279. doi:10.1016/j.aohep.2020.01.00232089501
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Sun F, et al. miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2. Oncol Lett. 2020;19:2265–2271.32194725
   PubMed Web of Science ®Google Scholar
• Ye J, Xiao X, Han Y, Fan D, Zhu Y, Yang L. MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells. Neoplasma. 2020;67:773–781. doi:10.4149/neo_2020_190730N68932726127
   PubMed Web of Science ®Google Scholar